Financials
- Market Capitalization 3.89 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1463 | DNLI Denali Therapeutics Inc. - Common Stock | 26.48 USD | +3.12% | +2.12% | +21.13% | +63.76% | 4.20 B USD | ||
| 1478 | TNGX Tango Therapeutics, Inc. - Common Stock | 28.36 USD | -8.69% | -6.43% | -9.48% | +358.16% | 4.10 B USD | ||
| 1535 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.48 USD | +0.03% | -0.03% | +0.38% | +48.42% | 3.85 B USD | ||
| 1553 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.97 USD | -1.53% | -7.11% | +12.74% | +73.85% | 3.72 B USD |
Frequently asked questions about NewAmsterdam Pharma Company N.V. - Ordinary Shares
What is the NewAmsterdam Pharma Company N.V. - Ordinary Shares stock price today?
The current price of NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS) is 33.28. Over the past 24 hours, the stock has changed by -5.62%. Follow the NAMS chart for real-time price dynamics.
What is the stock ticker of NewAmsterdam Pharma Company N.V. - Ordinary Shares?
NewAmsterdam Pharma Company N.V. - Ordinary Shares trades under the ticker NAMS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NewAmsterdam Pharma Company N.V. - Ordinary Shares stock going up?
NAMS has changed by -5.00% over the last week, +6.74% over the last month, and -8.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was NewAmsterdam Pharma Company N.V. - Ordinary Shares net income for the last quarter?
NewAmsterdam Pharma Company N.V. - Ordinary Shares reported net income of -48.44 M for the last quarter. The previous quarter showed -74.92 M, which means net income changed by +35.35%.
How many employees does NewAmsterdam Pharma Company N.V. - Ordinary Shares have?
As of the latest available data, NewAmsterdam Pharma Company N.V. - Ordinary Shares has 100 employees. Workforce size can provide additional context about the company's scale and operations.
What is NewAmsterdam Pharma Company N.V. - Ordinary Shares EBITDA?
NewAmsterdam Pharma Company N.V. - Ordinary Shares EBITDA is -65.93 M, and its EBITDA margin is -2 168.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NewAmsterdam Pharma Company N.V. - Ordinary Shares stock?
You can buy NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NewAmsterdam Pharma Company N.V. - Ordinary Shares stock?
Investing in NewAmsterdam Pharma Company N.V. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NAMS chart and related analysis on metatrader.com as part of your research.